Ronald M MD Kurtz insider trades: RxSight (RXST) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | RXST | ↓ Sell | 5,100 | $6.96 | $35K | Direct | Sep 2, 2026 (0d) |
| May 3, 2024 | RXST | ↓ Sell | 40,000 | $60.15 | $2.4M | Indirect | May 6, 2024 (3d) |
| Jan 8, 2024 | RXST | ↓ Sell | 62,500 | $44.25 | $2.8M | Indirect | Jan 9, 2024 (1d) |
| Dec 27, 2023 | RXST | ↓ Sell | 22,500 | $41.09 | $924K | Indirect | Dec 29, 2023 (2d) |
| Dec 14, 2023 | RXST | ↓ Sell | 40,000 | $39.70 | $1.6M | Indirect | Dec 18, 2023 (4d) |
| Aug 5, 2021 | RXST | ↑ Buy | 3,638 | $13.85 | $50K | Indirect | Aug 5, 2021 (0d) |
| Aug 3, 2021 | RXST | ↑ Buy | 125,000 | $16.00 | $2.0M | Direct | Aug 5, 2021 (2d) |
| Aug 8, 2005 | ILSE | ↓ Sell | 2,000 | $19.48 | $39K | by Trust | Aug 9, 2005 (1d) |
| Aug 1, 2005 | ILSE | ↓ Sell | 15,000 | $20.86 | $313K | by Trust | Aug 1, 2005 (0d) |
| Jul 27, 2005 | ILSE | ↓ Sell | 6,000 | $21.99 | $132K | by Trust | Jul 28, 2005 (1d) |
| Jul 26, 2005 | ILSE | ↓ Sell | 12,000 | $18.93 | $227K | by Trust | Jul 27, 2005 (1d) |
| Jul 18, 2005 | ILSE | ↓ Sell | 9,000 | $18.04 | $162K | by Trust | Jul 19, 2005 (1d) |
| Jul 14, 2005 | ILSE | ↓ Sell | 3,000 | $20.88 | $63K | by Trust | Jul 15, 2005 (1d) |
| Jul 11, 2005 | ILSE | ↓ Sell | 12,000 | $19.89 | $239K | by Trust | Jul 11, 2005 (0d) |
| Jul 5, 2005 | ILSE | ↓ Sell | 12,000 | $19.93 | $239K | by Trust | Jul 6, 2005 (1d) |
| Jun 27, 2005 | ILSE | ↓ Sell | 12,000 | $19.52 | $234K | by Trust | Jun 28, 2005 (1d) |
| Jun 20, 2005 | ILSE | ↓ Sell | 9,000 | $19.15 | $172K | by Trust | Jun 22, 2005 (2d) |
| Jun 14, 2005 | ILSE | ↓ Sell | 18,000 | $19.03 | $342K | by Trust | Jun 15, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RXST insiders
Open-market trades in the last 12 months
About Ronald M MD Kurtz's insider trades
Ronald M MD Kurtz is Chief Medical Officer at RxSight (RXST). Since Jun 14, 2005, Ronald has reported 2 open-market purchases worth $2.1M and 16 sales worth $9.9M on SEC Form 4. In the last 12 months: 1 sale ($35K).
Their filings also include grants and awards (5 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RXST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.